@PDisterer

Freelance Science Writer

 London, England
Joined August 2016
  • Tweets989
  • Following265
  • Followers375
24Media
Petra Disterer, MSc, PhD. retweeted
Petra Disterer, MSc, PhD.@PDisterer5 Jul 2024
Replying to @UPS_UK
@UPS_UK Yet again UPS are trying to scam me into paying import tax on a delivery that does NOT require import tax to be paid. Maybe you could actually train your agents on UK law?
4
1
145
Petra Disterer, MSc, PhD. retweeted
Chirag Shah@chiragontwtr4 Jan 2021
$ions $arwr
This Post is from an account that no longer exists. Learn more
1
1
7
Petra Disterer, MSc, PhD. retweeted
Karousis Lab@RNAkook2 Aug 2020
Special emphasis on point 7 😜
༻Ras⏣uli H༺@H3nRasouli1 Aug 2020
Ten simple rules for reading a scientific paper journals.plos.org/ploscompbi…
1
Petra Disterer, MSc, PhD. retweeted
Sarah@sarah_aslannnn10 Jul 2020
Replying to @Richard59085991 @THumphreyson @PDisterer @YouGov
I'm sorry thats just not true, both from published evidence and anecdotally from wearing a mask for months on end for hours at a time. There has been no demonstrable adverse effect on any of my colleagues. I understand that they feel uncomfortable - but they aren't dangerous!
1
3
4
Petra Disterer, MSc, PhD. retweeted
Shawn Titcomb@shawntitcomb4 Jun 2020
Great to see continued pharma interest in RNA therapeutics - AstraZeneca puts $55M into Accent as pharmas continue push to drug RNA biopharmadive.com/news/astra… via @BioPharmaDive $AZN $ALNY $ARCT $ARWR $DRNA $IONS $MRNA $NBSE $PRQR $SLN.N $STOK $WVE $XCUR $IBB $XBI

AstraZeneca puts $55M into Accent as pharmas continue push to drug RNA

The deal follows similar pacts involving Merck, Biogen, Roche and others, reflecting growing interest by pharmaceutical companies in the emerging field. 

biopharmadive.com
3
3
Petra Disterer, MSc, PhD. retweeted
Prof Dr Michela A Denti@michela_denti4 Jun 2020
Neurodegenerative diseases: UniTrento takes on the challenge | UniTrento Press Room pressroom.unitn.it/comunicat…
1
2
3
Petra Disterer, MSc, PhD. retweeted
PharmaVoice@PharmaVoice20 May 2020
Did you happen to see Dr. Holly Kordasiewicz's work on the Ken Burns series The Gene? Listen to today's #WoW podcast to hear how she and the @Ionispharma team are forging forward on many therapeutic research levels to address neurodegenerative diseases. pharmavoice.com/wow-podcasts…
3
2
10
Petra Disterer, MSc, PhD. retweeted
Timmerman Report@timmermanreport12 May 2020
Science in plain English for the pandemic. Watch @ArtKrieg of @OTSociety 14-minute video and short text Q&A. Then ask: How can you lever your expertise for science education? timmermanreport.com/2020/05/…
3
5
Petra Disterer, MSc, PhD. retweeted
Ana Mingorance@CNSdrughunter12 May 2020
Attention rare disease scientists and patients interested in N-of-1 clinical trials. Here is an excellent document for what you should consider. It focuses on ASOs but much is applicable to other N-of-1 genetic approaches 👇👇👇
AnnemiekeAartsma-Rus@oligogirl12 May 2020
⁦@OTSociety⁩ planned a meeting to discuss development of Oligonucleotide Therapies for very small patient cohorts. Due to the COVID-19 pandemic the meeting is postponed. However I’m proud to present our briefing document - we welcome your comments! oligotherapeutics.org/briefi…
11
26
Petra Disterer, MSc, PhD. retweeted
AnnemiekeAartsma-Rus@oligogirl12 May 2020
⁦@OTSociety⁩ planned a meeting to discuss development of Oligonucleotide Therapies for very small patient cohorts. Due to the COVID-19 pandemic the meeting is postponed. However I’m proud to present our briefing document - we welcome your comments! oligotherapeutics.org/briefi…
1
13
7
26
Petra Disterer, MSc, PhD. retweeted
Art Krieg@ArtKrieg12 May 2020
Oligonucleotide therapeutics may stop this pandemic, and that's our top priority right now. But we also want to accelerate their development to treat ultra-rare diseases. Here's our plan.
AnnemiekeAartsma-Rus@oligogirl12 May 2020
Thanks to everyone who contributed to the document but especially to partners in crime @ArtKrieg @jwattsgroup and @timyu
7
32
Petra Disterer, MSc, PhD. retweeted
AnnemiekeAartsma-Rus@oligogirl7 May 2020
⁦@ArtKrieg⁩ and ⁦@OTSociety⁩ have generated videos about oligotherapies and COVID-19. One scientific and one for lay people. Oligonucleotide Therapies and COVID-19 - Oligonucleotide Therapeutics Society oligotherapeutics.org/oligon…

Oligonucleotide Therapies and COVID-19 - Oligonucleotide Therapeutics Society

In response to the COVID-19 pandemic, scientists around the world have joined together in applying their skills and technologies to fight this global threat. Some of the most promising technologies...

oligotherapeutics.org
7
13
Petra Disterer, MSc, PhD. retweeted
Luke Timmerman@ldtimmerman6 May 2020
Webinar by @ArtKrieg on oligonucleotide therapies for COVID-19. One short, accessible version for lay audiences and a longer, more technical version for scientists. Nicely done! oligotherapeutics.org/oligon…
9
2
34
Petra Disterer, MSc, PhD. retweeted
Dr. Saskia Popescu
@SaskiaPopescu24 Apr 2020
I can’t believe we have to say this...
Sam Ghali, M.D.
@EM_RESUS23 Apr 2020
Hi, ER Doc here. Do NOT inject or consume ANY disinfectants in an attempt to kill COVID19.
5
54
3
256
Petra Disterer, MSc, PhD. retweeted
Jen Heemstra@jenheemstra19 Apr 2020
If you’ve ventured out lately, you’ve probably noticed lots of people wearing gloves. At the grocery store. Driving their car. Even when out walking their dog. Does this protect against #COVID19? The answer is that gloves are only as effective as how you use them. A thread.
22
242
55
521
Petra Disterer, MSc, PhD. retweeted
Benjamin Alvarez@BenjAlvarez115 Apr 2020
This is how Angela Merkel explained the effect of a higher #covid19 infection rate on the country's health system. This part of today's press conf was great, so I just added English subtitels for all non-German speakers. #flattenthecurve
2,185
30,855
12,173
77,873
Petra Disterer, MSc, PhD. retweeted
Petra Disterer, MSc, PhD.@PDisterer28 Mar 2020
Replying to @Ocado
@ocado Dear Ocado, I’m a SmartPass customer and just got an email to log in and place my order. Great! Only problem is that NO delivery slots are showing. Some technical issues there? How about you just assign slots based on geography?
1
1
The first OTS Journal Club will be on Thursday, March 26, 15.00 UTC “Nucleic acid-based applications in human health” Presenter: Erin M. McConnell (McMaster University) @Bluebird__47 Other speakers @DahlmanLab @DANorDNA Sign up here: oligotherapeutics.org/journa… Pic @PHDcomics
1
5
2
10
So one thought I had - with labs shut down could they donate their stocks of PPE such as gloves, paper suits, plastic overshoes and N95 respirators to their local hospitals?
4
2
1
5
Petra Disterer, MSc, PhD. retweeted
RNA_Biotech@RNA_Biotech16 Mar 2020
$BNTX rapid progress #COVID19 #mRNA #vaccine #BNT162 - start of clinical testing for vaccine in late April 2020 - plans to assemble global consortium of partners - 1st partner Fosun Pharma (china) will pay BioNTech up to 135M finance.yahoo.com/news/biont… finance.yahoo.com/news/biont…
1
2
2
8
Load more